Article info

Download PDFPDF

442-N RNA primed SMAR-TTM cells against multiple driver mutations, all HLA’s, designed for first line therapy

Authors

Citation

Barry W, Muzaffar F, Srivatsa S, et al
442-N RNA primed SMAR-TTM cells against multiple driver mutations, all HLA’s, designed for first line therapy

Publication history

  • First published October 31, 2023.
Online issue publication 
December 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.